dacarbazine has been researched along with Thromboembolism in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, WX; Gu, L; Guo, XW; Huang, XE; Liu, YC; Yin, XX; Zhou, SB | 1 |
Laigle-Donadey, F; Sanson, M | 1 |
Becker, JC; Bröcker, EB; Klingert, S; Winkler, B | 1 |
Bellet, RE; Berd, D; Mastrangelo, MJ; McClay, EF | 1 |
1 review(s) available for dacarbazine and Thromboembolism
Article | Year |
---|---|
[Pattern of care of high-grade gliomas].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Epilepsy; Forecasting; Genetic Markers; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Oligodendroglioma; Prognosis; Quality of Life; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Survival Analysis; Temozolomide; Thromboembolism; Time Factors; Tomography, X-Ray Computed | 2006 |
1 trial(s) available for dacarbazine and Thromboembolism
Article | Year |
---|---|
Clinical observation of three dimensional conformal radiotherapy with tamoxifen in treatment of postoperative malignant glioma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Postoperative Period; Radiotherapy, Conformal; Random Allocation; Survival Rate; Tamoxifen; Temozolomide; Thromboembolism; Treatment Outcome; Young Adult | 2015 |
2 other study(ies) available for dacarbazine and Thromboembolism
Article | Year |
---|---|
Antiphospholipid syndrome associated with immunotherapy for patients with melanoma.
Topics: Adult; Aged; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antineoplastic Combined Chemotherapy Protocols; Antiphospholipid Syndrome; Autoantibodies; Cardiolipins; Carmustine; Chemotherapy, Adjuvant; Cisplatin; Dacarbazine; Female; Humans; Immunoglobulin G; Immunotherapy; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Recombinant Proteins; Tamoxifen; Thromboembolism | 1994 |
Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Dacarbazine; Female; Humans; Kidney Diseases; Leukopenia; Male; Melanoma; Middle Aged; Nausea; Pulmonary Embolism; Skin Neoplasms; Tamoxifen; Thrombocytopenia; Thromboembolism; Vomiting | 1987 |